Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
December 2006
2006:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2007 | 2008
News | News in brief | News Features
News
Animal experiments under fire for poor design
A British team analyzing the usefulness of animal experimentation claims that experiments are often poorly designed, and so fail to lay the ground properly for subsequent human studies.
Nature (21 December 2006)
| Full Text |
NIH offers free access to wealth of disease data
A web-based portal containing information about the genes, health and lifestyles of thousands of subjects will allow any interested investigator to search across multiple epidemiological studies, in the hope of identifying new links to disease.
Nature (21 December 2006)
| Full Text |
Better, faster — and easier to use
The Pentagon is sinking millions of dollars into developing the next generation of supercomputers — and plans to let non-military scientists and engineers share the benefits.
Nature (21 December 2006)
| Full Text |
Biotech takes aim at large anti-estrogen markets
Next year, San Diego-based Ligand Pharmaceuticals is hoping to launch a third-generation selective estrogen receptor modulator (SERM) that it developed with Wyeth of Collegeville, Pennsylvania.
Nature Biotechnology (December 2006)
| Full Text |
When good cholesterol turns bad
Last week's dramatic failure of a drug trial aimed at boosting 'good' cholesterol is bad news for Pfizer, the world's largest drug company. But will it also dash the hopes of those looking for a new way of preventing heart attacks?
Nature (14 December 2006)
| Full Text |
Changes at the helm fuel Salk expansion plans
Irwin Jacobs, an electrical engineer and chairman of San Diego-based Qualcomm, is the new leader of the Salk institute.
Nature (14 December 2006)
| Full Text |
Agency set up to tackle bioterror
A last minute deal in Congress pushes through a biodefense bill.
Nature (14 December 2006)
| Full Text |
Australia lifts ban on cloning
Australia becomes one of several countries, including Britain and South Korea, to specifically permit the creation of cloned embryos for research purposes under certain conditions.
Nature (14 December 2006)
| Full Text |
Stem-cell technique 'contrary to public order'
A German court has revoked a patent on a method for generating a class of human embryonic stem cells. The ruling is seen as yet another setback for an already tight research policy on stem cells.
Nature (14 December 2006)
| Full Text |
A vision of life after Blair
With Tony Blair stepping down as Britain's prime minister, UK scientists are wondering what a government led by Gordon Brown would be like.
Nature (14 December 2006)
| Full Text |
Journal reveals plans to fight fraud
The journal Science will begin targeting certain "high-risk" papers for extra scrutiny.
Nature (7 December 2006)
| Full Text |
Molecular HIV evidence backs accused medics
International experts in DNA forensics say that a paper published online in Nature this week provides a firm alibi for the six medical workers facing the death penalty in Libya.
Nature (7 December 2006)
| Full Text |
South Africa takes steps to tackle HIV
At last, the South African government has agreed to tackle the AIDS pandemic in a whole-hearted manner.
Nature (7 December 2006)
| Full Text |
Actions speak louder than images
Scientists are increasingly concerned that brain scans will be used to make dangerous legal or social judgments about people's behavior.
Nature (7 December 2006)
| Full Text |
Lou Gehrig's group dangles million-dollar bait for biomarker search
Prize4Life, a new philanthropic organization, will award $1 million to anyone who can find a biomarker for Lou Gehrig's disease, a fatal neurodegenerative illness.
Nature Medicine (December 2006)
| Full Text |
Breast cancer research neglects non-Jewish groups, experts charge
Soon after scientists identified the first genes linked to breast cancer, they discovered mutations among Ashkenazi Jews. But did this early success skew research into breast cancer?
Nature Medicine (December 2006)
| Full Text |
New chief brings welcome change to US cancer agency
John Niederhuber, the new director of the US National Cancer Institute (NCI), says politics has no role at the institute.
Nature Medicine (December 2006)
| Full Text |
Preprint analysis quantifies scientific plagiarism
A survey of a physics preprint database reveals that blatant deception is rare, but suggests that minor acts of misconduct may be more common than was previously thought.
Nature (30 November 2006)
| Full Text |
Amazon puts network power online
Researchers can now use the computing power of large web companies instead of academic in-house IT resources.
Nature (30 November 2006)
| Full Text |
News in brief
Cow-human chimaera for stem cells faces UK ban
| Norway plans for innovation
| Former FDA head pleads guilty
| US salaries for women in life sciences still lagging
| Cephalon/Ambit kinase deal
| Novartis opens R&D center in China
| US public unperturbed by skills shortage claims
| President quits California's stem-cell institute
| NIH researcher confesses to breach of ethics
| Senate vote ends months of waiting for FDA head
| Pfizer to get rights to drugs discovered at Scripps
| Conflicts of interest found on hospital review boards
| Online tool for Linux software proves popular
| Experimental journal puts science in the movies
| Max Planck Society plans expansion to United States
| Slovenians engineer win in genetics competition
News Features
Animal Research: A matter of life and death
This week's News Feature section focuses on animal research. Lab researchers working in different areas of biomedical science describe their attitude to the use of animals in scientific research.
| Full Text |
Year-end special
Nature Medicine draws a brief history of the important news stories this year.
Nature Medicine (December 2006)
| Full Text |
Notable advances
Nature Medicine editors comment on the papers that had the biggest impact this year.
Nature Medicine (December 2006)
| Full Text |
Plantecology: The cost of leafing
Understanding the trade-offs involved for plants making leaves promises fresh insights on every scale from the plant to the planet.
Nature (30 November 2006)
| Full Text |
The bitterest pill
Drug companies lose hundreds of millions of dollars when large-scale human clinical trials fail. But could alternative procedures help avoid such disappointments?
Nature (30 November 2006)
| Full Text |
|
